Breaking News
1. Anger against Khalistanis spills onto Canada streets; Hindus, Sikhs unite      2. 'Madrassas gave IAS, IPS officers': How Muslim bodies reacted to Supreme Court verdict      3. Two Supreme Court judges on nine-judge Bench refer to CJI’s ‘harsh’ criticism of Krishna Iyer in a ‘proposed judgment’      4. Diwali celebrations hit air quality in New Delhi      5. Congress on EC's response on Haryana polls complaint: ‘Gave clean chit to itself’      6. Uddhav faction MP stokes row with sexist jibe at Shaina NC, she hits back      7. India silent after U.S. sanctions 19 Indian entities for ‘Russia links’      8. Congress stands badly exposed over fake promises: PM Modi      9. 2 Migrant Workers From UP Shot At In Terrorist Attack In J&K's Budgam      10. 7-year-old dies after falling into drain      11. Tirupati temple receive bomb threat again      12. ED attaches assets worth Rs 500 crore in a bank fraud and money laundering case      13. Four months after abduction, gym trainer admits to murder, body recovered by police      14. Nine persons injured in stampede at Bandra railway station in Mumbai, says official      15. Delhi police recover suspicious device resembling mobile jammer in Palika Bazaar      16. Georgia ruling party wins polls      17. Russian forces take control of village of Izmailivka in Ukraine's Donetsk region      18. Japan ruling party misses majority in snap vote      19. Bombay HC grants bail to Deepak Deshmukh in money laundering case      20. BSF Meghalaya foils smuggling bid, seises contraband worth Rs 12 lakh along international border     

Covishield Production to Resume: SII Announces Amid Surge in COVID-19 Cases

  • Posted on April 13, 2023
  • News
  • By Arijit Dutta
  • 467 Views
1681365709-p1Yl9OLPKO.png
Covishield Production to Resume:-


As India fights a surge in Covid-19 cases, the Serum Institute of India (SII) has declared plans to restart the production of the Covishield antibody. The company, which is the world's biggest immunization producer by volume, stopped production in April after a fire broke out at its Pune office. 


Covishield Production to Resume
Covishield Production to Resume

SII CEO Adar Poonawalla said that the company had taken all fundamental measures to guarantee the security of its laborers, upon which manufacturing of vaccines would start in a staged manner.


Covishield, an immunization formulation developed utilizing the Oxford-AstraZeneca vaccine, constitutes one of the two vaccines currently administered in India's widespread immunization campaign. 


Notwithstanding, the nation has contemporaneously encountered an inadequacy of vaccines during the past few weeks, as multiple states have announced an insufficiency of available immunizations. It is anticipated that the resumption of manufacturing activities at the Serum Institute of India (SII) will provide a significant boost to the ongoing vaccination drive.


India is seeing a lot of people getting sick with Covid-19 lately. On top of that, India doesn't have enough oxygen cylinders and beds in hospitals, which is causing problems for Their healthcare system. With the restart in production of the Covishield vaccines by the SII, the hopes of curbing the virus before it turns out into another pandemic have found new light. 


Covishield Production to Resume
Covishield Production to Resume

For more such news, visit our website www.topstories.com, where we share unbiased and true stories of the world.

Author
No Image
Author
Arijit Dutta

You May Also Like